A citation-based method for searching scientific literature

N D Volkow, J S Fowler, G J Wang, J Logan, D Schlyer, R MacGregor, R Hitzemann, A P Wolf. Ann Neurol 1994
Times Cited: 145







List of co-cited articles
874 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT.
C H van Dyck, J P Seibyl, R T Malison, M Laruelle, E Wallace, S S Zoghbi, Y Zea-Ponce, R M Baldwin, D S Charney, P B Hoffer. J Nucl Med 1995
210
26


Age-related changes in the human nigrostriatal dopaminergic system.
J De Keyser, G Ebinger, G Vauquelin. Ann Neurol 1990
130
22

Dopamine transporters decrease with age.
N D Volkow, Y S Ding, J S Fowler, G J Wang, J Logan, S J Gatley, R Hitzemann, G Smith, S D Fields, R Gur. J Nucl Med 1996
205
19

Decreased density of human striatal dopamine uptake sites with age.
N Zelnik, I Angel, S M Paul, J E Kleinman. Eur J Pharmacol 1986
106
18

Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging.
K A Frey, R A Koeppe, M R Kilbourn, T M Vander Borght, R L Albin, S Gilman, D E Kuhl. Ann Neurol 1996
239
18

Effects of age on dopamine transporters in healthy humans.
P D Mozley, P D Acton, E D Barraclough, K Plössl, R C Gur, A Alavi, A Mathur, J Saffer, H F Kung. J Nucl Med 1999
81
20

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.
J P Seibyl, K L Marek, D Quinlan, K Sheff, S Zoghbi, Y Zea-Ponce, R M Baldwin, B Fussell, E O Smith, D S Charney,[...]. Ann Neurol 1995
384
16

Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.
N D Volkow, R C Gur, G J Wang, J S Fowler, P J Moberg, Y S Ding, R Hitzemann, G Smith, J Logan. Am J Psychiatry 1998
575
15

Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.
P D Mozley, H J Kim, R C Gur, K Tatsch, L R Muenz, W T McElgin, M P Kung, M Mu, A M Myers, H F Kung. J Nucl Med 1996
60
23

Aging and extrapyramidal function.
P L McGeer, E G McGeer, J S Suzuki. Arch Neurol 1977
534
14

Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.
M J Bannon, M S Poosch, Y Xia, D J Goebel, B Cassin, G Kapatos. Proc Natl Acad Sci U S A 1992
152
13

Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson's disease.
J J Frost, A J Rosier, S G Reich, J S Smith, M D Ehlers, S H Snyder, H T Ravert, R F Dannals. Ann Neurol 1993
297
13


Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging.
N D Volkow, G J Wang, J S Fowler, Y S Ding, R C Gur, J Gatley, J Logan, P J Moberg, R Hitzemann, G Smith,[...]. Ann Neurol 1998
129
13

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease.
C S Lee, A Samii, V Sossi, T J Ruth, M Schulzer, J E Holden, J Wudel, P K Pal, R de la Fuente-Fernandez, D B Calne,[...]. Ann Neurol 2000
366
13

Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease.
R B Innis, J P Seibyl, B E Scanley, M Laruelle, A Abi-Dargham, E Wallace, R M Baldwin, Y Zea-Ponce, S Zoghbi, S Wang. Proc Natl Acad Sci U S A 1993
345
12

[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease.
K L Marek, J P Seibyl, S S Zoghbi, Y Zea-Ponce, R M Baldwin, B Fussell, D S Charney, C van Dyck, P B Hoffer, R P Innis. Neurology 1996
299
12

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
P K Morrish, J S Rakshi, D L Bailey, G V Sawle, D J Brooks. J Neurol Neurosurg Psychiatry 1998
368
12

Human brain dopamine receptors in children and aging adults.
P Seeman, N H Bzowej, H C Guan, C Bergeron, L E Becker, G P Reynolds, E D Bird, P Riederer, K Jellinger, S Watanabe. Synapse 1987
347
12


Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease.
J M Wilson, A I Levey, A Rajput, L Ang, M Guttman, K Shannak, H B Niznik, O Hornykiewicz, C Pifl, S J Kish. Neurology 1996
169
11

Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
E Nurmi, H M Ruottinen, V Kaasinen, J Bergman, M Haaparanta, O Solin, J O Rinne. Ann Neurol 2000
88
12

Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.
T Ishikawa, V Dhawan, K Kazumata, T Chaly, F Mandel, J Neumeyer, C Margouleff, B Babchyck, I Zanzi, D Eidelberg. J Nucl Med 1996
143
11


Age-related cognitive deficits mediated by changes in the striatal dopamine system.
L Bäckman, N Ginovart, R A Dixon, T B Wahlin, A Wahlin, C Halldin, L Farde. Am J Psychiatry 2000
302
11

Age-related decline in dopamine transporters: analysis of striatal subregions, nonlinear effects, and hemispheric asymmetries.
Christopher H van Dyck, John P Seibyl, Robert T Malison, Marc Laruelle, Sami S Zoghbi, Ronald M Baldwin, Robert B Innis. Am J Geriatr Psychiatry 2002
162
11


Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations.
H Bernheimer, W Birkmayer, O Hornykiewicz, K Jellinger, F Seitelberger. J Neurol Sci 1973
10


Striatal dopamine transporters and cognitive functioning in healthy men and women.
L H Mozley, R C Gur, P D Mozley, R E Gur. Am J Psychiatry 2001
214
10

Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brain.
V Kaasinen, H Vilkman, J Hietala, K Någren, H Helenius, H Olsson, L Farde, J Rinne. Neurobiol Aging 2000
230
10

The vesicular monoamine transporter is not regulated by dopaminergic drug treatments.
T Vander Borght, M Kilbourn, T Desmond, D Kuhl, K Frey. Eur J Pharmacol 1995
170
9

Binding of [99mTc]TRODAT-1 to dopamine transporters in patients with Parkinson's disease and in healthy volunteers.
P D Mozley, J S Schneider, P D Acton, K Plössl, M B Stern, A Siderowf, N A Leopold, P Y Li, A Alavi, H F Kung. J Nucl Med 2000
138
9

Age-related changes in human D1 dopamine receptors measured by positron emission tomography.
T Suhara, H Fukuda, O Inoue, T Itoh, K Suzuki, T Yamasaki, Y Tateno. Psychopharmacology (Berl) 1991
158
9

Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels.
B J Snow, I Tooyama, E G McGeer, T Yamada, D B Calne, H Takahashi, H Kimura. Ann Neurol 1993
271
9

Regional analysis of age-related decline in dopamine transporters and dopamine D2-like receptors in human striatum.
Kenji Ishibashi, Kenji Ishii, Keiichi Oda, Keiichi Kawasaki, Hidehiro Mizusawa, Kiichi Ishiwata. Synapse 2009
69
13

Linking cognitive aging to alterations in dopamine neurotransmitter functioning: recent data and future avenues.
Lars Bäckman, Ulman Lindenberger, Shu-Chen Li, Lars Nyberg. Neurosci Biobehav Rev 2010
211
9

Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects.
M Laruelle, E Wallace, J P Seibyl, R M Baldwin, Y Zea-Ponce, S S Zoghbi, J L Neumeyer, D S Charney, P B Hoffer, R B Innis. J Cereb Blood Flow Metab 1994
265
8

Imaging serotonin and dopamine transporters with 123I-beta-CIT SPECT: binding kinetics and effects of normal aging.
W Pirker, S Asenbaum, M Hauk, S Kandlhofer, J Tauscher, M Willeit, A Neumeister, N Praschak-Rieder, P Angelberger, T Brücke. J Nucl Med 2000
144
8

Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate.
N D Volkow, G J Wang, J S Fowler, S J Gatley, J Logan, Y S Ding, R Hitzemann, N Pappas. Am J Psychiatry 1998
605
8






Nigrostriatal function in humans studied with positron emission tomography.
W R Martin, M R Palmer, C S Patlak, D B Calne. Ann Neurol 1989
281
8

Imaging of dopamine transporters with iodine-123-beta-CIT and SPECT in Parkinson's disease.
S Asenbaum, T Brücke, W Pirker, I Podreka, P Angelberger, S Wenger, C Wöber, C Müller, L Deecke. J Nucl Med 1997
131
8

Age-dependent decline in human brain dopamine D1 and D2 receptors.
J O Rinne, P Lönnberg, P Marjamäki. Brain Res 1990
158
8

Genotype influences in vivo dopamine transporter availability in human striatum.
A Heinz, D Goldman, D W Jones, R Palmour, D Hommer, J G Gorey, K S Lee, M Linnoila, D R Weinberger. Neuropsychopharmacology 2000
428
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.